ResMed (RMD) PT Lowered to $220 at Mizuho
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.74 --0%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Mizuho analyst Anthony Petrone lowered the price target on ResMed (NYSE: RMD) to $220.00 (from $235.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- Ecopetrol SA (EC) PT Raised to $16 at UBS
- Yesway Inc (YSWY) PT Raised to $27 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
